A. T. Taher Et Al. , "Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study," BLOOD , vol.131, no.2, pp.263-265, 2018
Taher, A. T. Et Al. 2018. Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study. BLOOD , vol.131, no.2 , 263-265.
Taher, A. T., Karakas, Z., Cassinerio, E., Siritanaratkul, N., Kattamis, A., Maggio, A., ... Rivella, S.(2018). Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study. BLOOD , vol.131, no.2, 263-265.
Taher, Ali Et Al. "Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study," BLOOD , vol.131, no.2, 263-265, 2018
Taher, Ali T. Et Al. "Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study." BLOOD , vol.131, no.2, pp.263-265, 2018
Taher, A. T. Et Al. (2018) . "Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study." BLOOD , vol.131, no.2, pp.263-265.
@article{article, author={Ali T. Taher Et Al. }, title={Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study}, journal={BLOOD}, year=2018, pages={263-265} }